Search

Your search keyword '"liver transplantation/hepatology"' showing total 64 results

Search Constraints

Start Over You searched for: Descriptor "liver transplantation/hepatology" Remove constraint Descriptor: "liver transplantation/hepatology" Journal american journal of transplantation Remove constraint Journal: american journal of transplantation
64 results on '"liver transplantation/hepatology"'

Search Results

1. Successful liver transplantation in patients with active SARS-CoV-2 infection.

2. Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab

3. Not everything that counts can be counted: Tracking long-term outcomes in pediatric liver transplant recipients

4. Mortality among solid organ waitlist candidates during COVID‐19 in the United States

5. Neighborhood socioeconomic deprivation is associated with worse patient and graft survival following pediatric liver transplantation

6. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates

7. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation

8. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice

9. Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates

10. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation

11. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials

12. Recipient HO‐1 inducibility is essential for posttransplant hepatic HO‐1 expression and graft protection: From bench‐to‐bedside

13. Physical frailty after liver transplantation

14. Serelaxin induces Notch1 signaling and alleviates hepatocellular damage in orthotopic liver transplantation

15. Heme oxygenase-1 regulates sirtuin-1–autophagy pathway in liver transplantation: From mouse to human

16. Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database

17. Sex-based disparities in delisting for being “too sick” for liver transplantation

18. Justifying Nonstandard Exception Requests for Pediatric Liver Transplant Candidates: An Analysis of Narratives Submitted to the United Network for Organ Sharing, 2009–2014

19. Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates

20. ABO‐Nonidentical Liver Transplantation in the United States

21. Commercially Available Immunoglobulins Contain Virus Neutralizing Antibodies Against All Major Genotypes of Polyomavirus BK

22. Survival Benefit of Repeat Liver Transplantation in the United States: A Serial MELD Analysis by Hepatitis C Status and Donor Risk Index

23. Prolonged preservation by hypothermic machine perfusion facilitates logistics in liver transplantation

24. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

25. Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study

26. Donor genetic variants as risk factors for thrombosis after liver transplantation

27. Third-party bone marrow–derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial

28. Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor

29. Organ transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia

30. Multisystem inflammatory syndrome in children associated with SARS‐CoV‐2 in a solid organ transplant recipient

31. Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation

32. Validation of the Model for End‐stage Liver Disease sodium (MELD‐Na) score in the Eurotransplant region

33. The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy

34. Split liver transplantation is utilized infrequently and concentrated at few transplant centers in the United States

35. Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study

36. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates

37. Venous outflow in partial heterotopic liver transplantation with spleen replacement: Evidence of no chronic venous hypertension

38. Hypoxia protects the liver from Small For Size Syndrome: A lesson learned from the associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure in rats

39. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice

40. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution

41. Report from the American Society of Transplantation on frailty in solid organ transplantation

42. Burkholderia multivorans septicemia in a pediatric liver transplant patient

43. Recipient HO-1 inducibility is essential for posttransplant hepatic HO-1 expression and graft protection: From bench-to-bedside

44. Improved survival after LTx-associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single-center experience and systematic review

45. MELD-based allocation at 20: Can we evolve and mature?

46. Early liver transplantation after COVID‐19 infection: The first report

47. Recovery from COVID‐19 following hepatitis C, human immunodeficiency virus infection, and liver transplantation

48. COVID‐19: A global transplant perspective on successfully navigating a pandemic

49. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

50. Posttransplant muscle mass measured by urinary creatinine excretion rate predicts long‐term outcomes after liver transplantation

Catalog

Books, media, physical & digital resources